Business & Consumer Services » Business Services | Interpace Diagnostics Group Inc.

Interpace Diagnostics Group Inc.

Interpace Diagnostics Group Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.41
Market Cap
$27.05 M
Shares Outstanding
38.1 M
Public Float
37.41 M

Profile

Address
Morris Corporate Center 1
Parsippany New Jersey 07054
United States
Employees -
Website http://www.interpacediagnostics.com
Updated 07/08/2019
Interpace Diagnostics Group, Inc. is an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. The company was founded by John P.

Financials

View All

Jack E. Stover
President, Chief Executive Officer & Director
Felice Schnoll Sussman
Director